Skip to main content

Market Overview

Mid-Morning Market Update: Markets Open Higher; Eli Lilly Beats Q1 Views

Share:

Following the market opening Thursday, the Dow traded up 0.81% to 23666.72 while the NASDAQ rose 0.99% to 8579.06. The S&P also rose, gaining 0.88% to 2824.03.

The U.S. is the epicenter of the coronavirus pandemic with the highest number of cases and deaths around the world. U.S. reported a total of 842,620 coronavirus cases with around 46,780 deaths. Spain confirmed a total of over 213,020 coronavirus cases with 22,150 deaths, while Italy reported a total of at least 187,320 confirmed cases and 25,080 deaths. In total, there were at least 2,645,090 cases of COVID-19 worldwide with over 184,260 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Energy shares climbed 2.6% on Thursday. Meanwhile, top gainers in the sector included Denbury Resources Inc. (NYSE: DNR), up 28%, and QEP Resources, Inc. (NYSE: QEP), up 25%.

In trading on Thursday, utilities shares fell 0.2%.

Top Headline

Eli Lilly And Co (NYSE: LLY) reported better-than-expected results for its first quarter.

Eli Lilly posted quarterly earnings of $1.75 per share, beating analysts’ estimates of $1.48 per share. Its sales came in at $5.86 billion, versus expectations of $5.51 billion.

Eli Lilly said it now expects FY20 adjusted earnings of $6.70 to $6.90 per share, and sales of $23.7 billion to $24.2 billion.

Equities Trading UP

CounterPath Corporation (NASDAQ: CPAH) shares shot up 55% to $3.4297 after the company provided Q1 and 2020 guidance and said it is experiencing 'strong demand' for its products as a result of the coronavirus pandemic.

Shares of Enzo Biochem, Inc. (NYSE: ENZ) got a boost, shooting 29% to $2.80 after the company highlighted launch of proprietary coronavirus diagnostic test under FDA's emergency use authorization.

Immunomedics, Inc. (NASDAQ: IMMU) shares were also up, gaining 25% to $27.50 after the FDA granted accelerated approval for the company's Trodelvy in previously-treated metastatic triple-negative breast cancer.

Equities Trading DOWN

Immunic, Inc. (NASDAQ: IMUX) shares tumbled 18% to $8.92. Immunic priced its 1.764 million share common stock offering to Altium Capital at $8.50 per share.

Shares of NETGEAR, Inc. (NASDAQ: NTGR) were down 17% to $21.53 after the company reported Q1 results and withdrew its guidance.

The Peck Company Holdings, Inc. (NASDAQ: PECK) was down, falling 13% to $4.96 after gaining 64% on Wednesday.

Commodities

In commodity news, oil traded up 11.8% to $15.40, while gold traded up 0.7% to $1,750.70.

Silver traded up 1.7% Thursday to $15.605, while copper rose 0.3% to $2.296.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.2%, the Spanish Ibex Index rose 0.6%, while Italy’s FTSE MIB Index rose 1%. Meanwhile, the German DAX dropped 0.2%, and the French CAC 40 rose 0.2% while UK shares fell 0.1%.

Economics

New U.S. jobless claims for the week ending April 17 totaled a whopping 4.427 million versus the 4.2 million estimate, according to numbers reported Thursday by the Bureau of Labor Statistics.

The IHS Markit composite PMI dipped to 27.4 in April, versus 40.9 in the prior month.

Sales of new homes in the U.S. dropped 15.4% to an annual rate of 627,000 in March.

The Energy Information Administration’s weekly report on natural gas stocks in underground storage is scheduled for release at 10:30 a.m. ET.

The Kansas City Fed manufacturing index for April is scheduled for release at 11:00 a.m. ET.

The Treasury is set to auction 4-and 8-week bills at 11:30 a.m. ET.

Data on money supply for the recent week will be released at 4:30 p.m. ET.

 

Related Articles (DNR + CPAH)

View Comments and Join the Discussion!

Posted-In: Mid-Morning Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com